Spectrum Management Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-41
Closed -$5K 375
2021
Q3
$5K Buy
+41
New +$5.31K ﹤0.01% 344
2020
Q4
Sell
-263
Closed -$27K 250
2020
Q3
$27K Buy
263
+200
+317% +$20.1K 0.01% 168
2020
Q2
$6K Buy
+63
New +$6.04K ﹤0.01% 222
2019
Q2
Sell
-413
Closed -$38K 257
2019
Q1
$38K Buy
413
+322
+354% +$28.8K 0.01% 150
2018
Q4
$8K Sell
91
-55
-38% -$5.14K ﹤0.01% 184
2018
Q3
$14K Hold
146
﹤0.01% 177
2018
Q2
$13K Buy
+146
New +$12.2K ﹤0.01% 183
2017
Q4
Sell
-2
Closed 342
2017
Q3
$0 Buy
+2
New +$166 ﹤0.01% 417

Other funds holding MDT

Spectrum Management Group's MDT Position: Q4 2021 in Review

Spectrum Management Group sold out of Medtronic (MDT) in Q4 2021, closing a stake of 41 shares — an estimated $5K sold.

Spectrum Management Group first reported a position in MDT in Q3 2017 and held it in 8 quarters. The position peaked at $38K in Q1 2019. 2,059 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

  • Spectrum Management Group reported no remaining Medtronic position as of Q4 2021 after selling out during the quarter.
  • Spectrum Management Group sold 41 Medtronic shares in Q4 2021, an estimated $5K.
  • Spectrum Management Group first reported a position in Medtronic in Q3 2017 and held it in 8 quarters.
  • Spectrum Management Group's Medtronic position peaked at $38K in Q1 2019.
  • 2,059 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on Spectrum Management Group's 13F filing for Q4 2021, filed 3 Feb 2022.